kt 5823 has been researched along with sirolimus in 1 studies
| Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (sirolimus) | Trials (sirolimus) | Recent Studies (post-2010) (sirolimus) |
|---|---|---|---|---|---|
| 317 | 0 | 59 | 20,711 | 2,368 | 11,516 |
| Protein | Taxonomy | kt 5823 (IC50) | sirolimus (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.25 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 2 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2 | |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Mus musculus (house mouse) | 0.001 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 4 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0897 | |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 0.0042 | |
| Regulatory-associated protein of mTOR | Homo sapiens (human) | 0.225 | |
| Target of rapamycin complex subunit LST8 | Homo sapiens (human) | 0.225 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 1.9 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, T; Kozuka-Hata, H; Oyama, M; Sakamoto, T; Seiki, M; Weng, JS; Yoshino, S | 1 |
1 other study(ies) available for kt 5823 and sirolimus
| Article | Year |
|---|---|
Hypoxia-inducible factor 1 regulation through cross talk between mTOR and MT1-MMP.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antibiotics, Antineoplastic; Carbazoles; Carrier Proteins; Cell Line, Tumor; Female; HEK293 Cells; Humans; Hypoxia-Inducible Factor 1; Immunoblotting; Matrix Metalloproteinase 14; Mice; Mice, Inbred BALB C; Mice, Nude; Mixed Function Oxygenases; Mutation; Neoplasms; Phosphorylation; Protein Binding; Protein Kinase Inhibitors; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sirolimus; TOR Serine-Threonine Kinases; Transplantation, Heterologous | 2014 |